TipRanks
Go Ultimate55% OFF

Stuhini Exploration (NOVA) AI Stock Analysis

TSE:NOVA

Stuhini Exploration

(TSXV:NOVA)

Select Model
Rating:56Neutral
Price Target:CAD 0.15â–²(19.20% Upside)
Action:reiterated
Date:01/24/26

Stuhini's strong balance sheet with no debt provides financial flexibility, but the company remains pre-revenue with ongoing losses. Technical indicators show a bullish trend, while valuation metrics are weak. The overall score reflects a speculative opportunity with moderate risk/reward.

Positive Factors
Low financial leverage (no debt)Zero reported debt reduces fixed obligations and lowers near-term solvency risk, giving management flexibility to prioritize exploration spending or partnerships without interest burdens. This durable capital structure helps sustain operations through extended exploration cycles.
Negative Factors
No revenue and recurring net lossesAbsence of any reported revenue and persistent net losses (TTM net loss ~1.47M) mean the company lacks operating income to fund exploration or demonstrate commercial viability. This structural lack of revenue keeps the business dependent on external capital and raises execution risk for long‑term value creation.

Stuhini Exploration (NOVA) vs. iShares MSCI Canada ETF (EWC)

-40%-20%0%20%40%60%TSE:NOVA-20.00%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CAD 4.47M
Dividend Yield
―
Average Volume (3M)
37.10K
Price to Earnings (P/E)
-6.4
Beta (1Y)
1.02
Revenue Growth
―
EPS Growth
42.72%
Country
Canada
Employees
0
Sector
Basic Materials
Sector Strength
61
Industry
Other Precious Metals

Stuhini Exploration Business Overview & Revenue Model

Company Description

EraNova Metals, Inc. engages in the acquisition and exploration of mineral properties. It focuses on the Ruby Creek Property, Big Ledge Zinc & South Thompson Project. The company was founded by Barry Hanslit and David Bruce O'Brien on July 7, 2017 an...

How the Company Makes Money

null

Stuhini Exploration Financial Statement Overview

Summary

Stuhini is pre-revenue with widening losses, typical for exploration. Balance sheet is strong with no debt and solid equity. Cash flow negative but manageable. Overall financial health is moderate.

Income Statement

15Very Negative

Balance Sheet

90Very Positive

Cash Flow

40Negative
Financial statement breakdown
BreakdownTTMMay 2024May 2023May 2022May 2021May 2020
Income Statement
Total Revenue000000
Gross Profit-222-327-97-208-463-695
EBITDA-707.42K-1.58M-492.02K-606.41K-294.21K-428.34K
Net Income-1.47M-1.41M-836.79K-604.86K-295.92K-431.49K
Balance Sheet
Total Assets10.27M10.26M9.69M6.47M3.32M1.70M
Cash, Cash Equivalents and Short-Term Investments492.67K537.72K1.16M1.16M1.16M957.10K
Total Debt000120.00K00
Total Liabilities154.92K122.50K524.38K356.11K83.78K116.98K
Stockholders Equity10.11M10.14M9.16M6.11M3.23M1.58M
Cash Flow
Free Cash Flow-921.00K-945.20K-3.14M-2.21M-1.54M-368.74K
Operating Cash Flow-581.20K-597.35K-726.22K-257.81K-445.06K-343.48K
Investing Cash Flow103.57K154.73K-2.39M-1.98M-1.08M-25.27K
Financing Cash Flow265.32K03.13M2.32M1.44M1.31M

Stuhini Exploration Technical Analysis

Technical Analysis SentimentNegative
Last Price0.13

Price Trends

50DMA0.15Negative
100DMA0.16Negative
200DMA0.17Negative

Market Momentum

MACD-0.01Positive
RSI39.81Neutral
STOCH16.67Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NOVA, the sentiment is Negative. The current price of 0.13 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.15, and below the 200-day MA of 0.17, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 39.81 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:NOVA.

Stuhini Exploration Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

TSE:NOVA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
TSE:NOVATSE:NOVA56NeutralCAD 6.69M-6.36-14.21%――42.72%
TSE:HARTSE:HAR46NeutralCAD 5.02M-2.38-15.68%―1077.69%37.31%
TSE:QMCTSE:QMC46NeutralCAD 3.12M-50.00-3.39%――63.33%
TSE:MEKTSE:MEK43NeutralCAD 11.44M-13.79-99.29%――30.95%
TSE:GOHTSE:GOH31UnderperformCAD 6.46M-3.93-23.00%――93.97%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%100%150%TSE:NOVATSE:MEKTSE:QMCTSE:HARTSE:GOHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
TSE:NOVA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:NOVAStuhini Exploration Ltd.0.12-0.02-17.24%
TSE:MEKMetals Creek Resources0.040.0014.29%
TSE:QMCQMC Quantum Minerals0.03-0.08-72.73%
TSE:HARHarfang Exploration, Inc.0.05-0.04-47.37%
TSE:GOHGoldhaven Resources Corp0.130.000.00%

Stuhini Exploration Corporate Events

Business Operations and Strategy

Restart Life Leverages Certified Plant to Scale Functional Wellness Brands

Positive
Mar 11, 2026

Restart Life Sciences is highlighting the strategic value of its Holy Crap manufacturing facility, which holds multiple third-party certifications including organic, kosher, non-GMO, SQF, and regulatory approvals in Canada and the U.S. These credenti...

Business Operations and Strategy

Restart Life Taps University of Manitoba to Bolster Science Behind Functional Foods

Positive
Mar 3, 2026

Restart Life Sciences has partnered with the University of Manitoba’s Richardson Centre for Food Technology and Research to support food-related scientific studies that will steer product development across its BrainQ, BrainBalls, Holy Crap, an...

Business Operations and StrategyFinancial DisclosuresM&A Transactions

Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition

Positive
Feb 27, 2026

Restart Life Sciences has closed its acquisition of Holy Crap Foods Inc., securing 100% ownership of the functional cereal brand and its related assets, including intellectual property, inventory, and longstanding retail and distributor relationships...

Business Operations and StrategyM&A Transactions

Restart Life Sciences to Acquire Holy Crap Foods in $1 Million Wellness Brand Deal

Positive
Feb 13, 2026

Restart Life Sciences Corp., a Canadian life sciences company, is expanding its footprint in health-focused consumer brands by acquiring Holy Crap Foods Inc., a premium breakfast cereal producer with a British Columbia-based manufacturing facility an...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jan 24, 2026